Owl Creek Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Owl Creek Wealth Partners's BMY Position: Q2 2026 in Review
Owl Creek Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 2.7% in Q2 2026, buying an estimated $2.58K and bringing the position to 1,699 shares worth $97.9K. The position accounts for 0.03% of the portfolio, ranked #201.
Owl Creek Wealth Partners first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $100K in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Owl Creek Wealth Partners held 1,699 shares of Bristol-Myers Squibb worth $97.9K as of Q2 2026.
- Owl Creek Wealth Partners bought 45 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.58K.
- Bristol-Myers Squibb made up 0.03% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #201 holding.
- Owl Creek Wealth Partners first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Owl Creek Wealth Partners's Bristol-Myers Squibb position peaked at $100K in Q1 2026.
- 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.